全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Pathogens  2013 

Evaluation of the Zoonotic Potential of Transmissible Mink Encephalopathy

DOI: 10.3390/pathogens2030520

Keywords: primate, prion, transgenic mice, TME, cattle, raccoon, zoonotic potential

Full-Text   Cite this paper   Add to My Lib

Abstract:

Successful transmission of Transmissible Mink Encephalopathy (TME) to cattle supports the bovine hypothesis for the still controversial origin of TME outbreaks. Human and primate susceptibility to classical Bovine Spongiform Encephalopathy (c-BSE) and the transmissibility of L-type BSE to macaques indicate a low cattle-to-primate species barrier. We therefore evaluated the zoonotic potential of cattle-adapted TME. In less than two years, this strain induced in cynomolgus macaques a neurological disease similar to L-BSE but distinct from c-BSE. TME derived from another donor species (raccoon) induced a similar disease with even shorter incubation periods. L-BSE and cattle-adapted TME were also transmissible to transgenic mice expressing human prion protein (PrP). Secondary transmissions to transgenic mice expressing bovine PrP maintained the features of the three tested bovine strains (cattle TME, c-BSE and L-BSE) regardless of intermediate host. Thus, TME is the third animal prion strain transmissible to both macaques and humanized transgenic mice, suggesting zoonotic potentials that should be considered in the risk analysis of animal prion diseases for human health. Moreover, the similarities between TME and L-BSE are highly suggestive of a link between these strains, and therefore the possible presence of L-BSE for many decades prior to its identification in USA and Europe.

References

[1]  Liberski, P.P.; Sikorska, B.; Guiroy, D.; Bessen, R.A. Transmissible mink encephalopathy - review of the etiology of a rare prion disease. Folia Neuropathol. 2009, 47, 195–204.
[2]  Marsh, R.F.; Bessen, R.A.; Lehmann, S.; Hartsough, G.R. Epidemiological and experimental studies on a new incident of transmissible mink encephalopathy. J. Gen. Virol. 1991, 72(Pt 3), 589–594.
[3]  Marsh, R.F.; Hadlow, W.J. Transmissible mink encephalopathy. Rev. Sci. Tech. 1992, 11, 539–550.
[4]  Harrington, R.D.; Baszler, T.V.; O'Rourke, K.I.; Schneider, D.A.; Spraker, T.R.; Liggitt, H.D.; Knowles, D.P. A species barrier limits transmission of chronic wasting disease to mink (mustela vison). J. Gen. Virol. 2008, 89, 1086–1096, doi:10.1099/vir.0.83422-0.
[5]  Robinson, M.M.; Hadlow, W.J.; Huff, T.P.; Wells, G.A.; Dawson, M.; Marsh, R.F.; Gorham, J.R. Experimental infection of mink with bovine spongiform encephalopathy. J. Gen. Virol. 1994, 75(Pt 9), 2151–2155.
[6]  Marsh, R.F.; Bessen, R.A. Epidemiologic and experimental studies on transmissible mink encephalopathy. Dev. Biol. Stand. 1993, 80, 111–118.
[7]  Hamir, A.N.; Kunkle, R.A.; Miller, J.M.; Bartz, J.C.; Richt, J.A. First and second cattle passage of transmissible mink encephalopathy by intracerebral inoculation. Vet. Pathol. 2006, 43, 118–126, doi:10.1354/vp.43-2-118.
[8]  Baron, T.; Bencsik, A.; Biacabe, A.G.; Morignat, E.; Bessen, R.A. Phenotypic similarity of transmissible mink encephalopathy in cattle and l-type bovine spongiform encephalopathy in a mouse model. Emerg. Infect. Dis. 2007, 13, 1887–1894, doi:10.3201/eid13112.070635.
[9]  Nicot, S.; Baron, T. Strain-specific barriers against bovine prions in hamsters. J. Virol. 2011, 85, 1906–1908, doi:10.1128/JVI.01872-10.
[10]  Casalone, C.; Zanusso, G.; Acutis, P.; Ferrari, S.; Capucci, L.; Tagliavini, F.; Monaco, S.; Caramelli, M. Identification of a second bovine amyloidotic spongiform encephalopathy: Molecular similarities with sporadic creutzfeldt-jakob disease. Proc. Natl. Acad. Sci. USA 2004, 101, 3065–3070, doi:10.1073/pnas.0305777101.
[11]  Capobianco, R.; Casalone, C.; Suardi, S.; Mangieri, M.; Miccolo, C.; Limido, L.; Catania, M.; Rossi, G.; Di Fede, G.; Giaccone, G.; et al. Conversion of the base prion strain into the bse strain: The origin of bse? PLoS Pathog. 2007, 3, e31, doi:10.1371/journal.ppat.0030031.
[12]  Baron, T.; Vulin, J.; Biacabe, A.G.; Lakhdar, L.; Verchere, J.; Torres, J.M.; Bencsik, A. Emergence of classical bse strain properties during serial passages of h-bse in wild-type mice. PLoS One 2011, 6, e15839.
[13]  Will, R.G.; Ironside, J.W.; Zeidler, M.; Cousens, S.N.; Estibeiro, K.; Alperovitch, A.; Poser, S.; Pocchiari, M.; Hofman, A.; Smith, P.G. A new variant of creutzfeldt-jakob disease in the uk. Lancet 1996, 347, 921–925, doi:10.1016/S0140-6736(96)91412-9.
[14]  Lasmezas, C.I.; Deslys, J.P.; Demaimay, R.; Adjou, K.T.; Lamoury, F.; Dormont, D.; Robain, O.; Ironside, J.; Hauw, J.J. Bse transmission to macaques. Nature 1996, 381, 743–744, doi:10.1038/381743a0.
[15]  Bruce, M.E.; Will, R.G.; Ironside, J.W.; McConnell, I.; Drummond, D.; Suttie, A.; McCardle, L.; Chree, A.; Hope, J.; Birkett, C.; et al. Transmissions to mice indicate that 'new variant' cjd is caused by the bse agent. Nature 1997, 389, 498–501, doi:10.1038/39057.
[16]  Brown, P.; Gibbs, C.J., Jr.; Rodgers-Johnson, P.; Asher, D.M.; Sulima, M.P.; Bacote, A.; Goldfarb, L.G.; Gajdusek, D.C. Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 1994, 35, 513–529, doi:10.1002/ana.410350504.
[17]  Lasmezas, C.I.; Comoy, E.; Hawkins, S.; Herzog, C.; Mouthon, F.; Konold, T.; Auvre, F.; Correia, E.; Lescoutra-Etchegaray, N.; Sales, N.; et al. Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet 2005, 365, 781–783.
[18]  Yutzy, B.; Holznagel, E.; Coulibaly, C.; Stuke, A.; Hahmann, U.; Deslys, J.P.; Hunsmann, G.; Lower, J. Time-course studies of 14-3-3 protein isoforms in cerebrospinal fluid and brain of primates after oral or intracerebral infection with bovine spongiform encephalopathy agent. J. Gen. Virol. 2007, 88, 3469–3478, doi:10.1099/vir.0.83128-0.
[19]  Krasemann, S.; Neumann, M.; Geissen, M.; Bodemer, W.; Kaup, F.J.; Schulz-Schaeffer, W.; Morel, N.; Aguzzi, A.; Glatzel, M. Preclinical deposition of pathological prion protein in muscle of experimentally infected primates. PLoS One 2010, 5, e13906, doi:10.1371/journal.pone.0013906.
[20]  Ono, F.; Terao, K.; Tase, N.; Hiyaoka, A.; Ohyama, A.; Tezuka, Y.; Wada, N.; Kurosawa, A.; Sato, Y.; Tobiume, M.; et al. Experimental transmission of bovine spongiform encephalopathy (bse) to cynomolgus macaques, a non-human primate. Jpn. J. Infect. Dis. 2011, 64, 50–54.
[21]  Comoy, E.E.; Casalone, C.; Lescoutra-Etchegaray, N.; Zanusso, G.; Freire, S.; Marce, D.; Auvre, F.; Ruchoux, M.M.; Ferrari, S.; Monaco, S.; et al. Atypical bse (base) transmitted from asymptomatic aging cattle to a primate. PLoS One 2008, 3, e3017, doi:10.1371/journal.pone.0003017.
[22]  Ono, F.; Tase, N.; Kurosawa, A.; Hiyaoka, A.; Ohyama, A.; Tezuka, Y.; Wada, N.; Sato, Y.; Tobiume, M.; Hagiwara, K.; et al. Atypical l-type bovine spongiform encephalopathy (l-bse) transmission to cynomolgus macaques, a non-human primate. Jpn. J. Infect. Dis. 2011, 64, 81–84.
[23]  Beringue, V.; Le Dur, A.; Tixador, P.; Reine, F.; Lepourry, L.; Perret-Liaudet, A.; Haik, S.; Vilotte, J.L.; Fontes, M.; Laude, H. Prominent and persistent extraneural infection in human prp transgenic mice infected with variant cjd. PLoS One 2008, 3, e1419, doi:10.1371/journal.pone.0001419.
[24]  Beringue, V.; Herzog, L.; Reine, F.; Le Dur, A.; Casalone, C.; Vilotte, J.L.; Laude, H. Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg. Infect. Dis. 2008, 14, 1898–1901, doi:10.3201/eid1412.080941.
[25]  Kong, Q.; Zheng, M.; Casalone, C.; Qing, L.; Huang, S.; Chakraborty, B.; Wang, P.; Chen, F.; Cali, I.; Corona, C.; et al. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J. Virol. 2008, 82, 3697–3701, doi:10.1128/JVI.02561-07.
[26]  Wilson, R.; Plinston, C.; Hunter, N.; Casalone, C.; Corona, C.; Tagliavini, F.; Suardi, S.; Ruggerone, M.; Moda, F.; Graziano, S.; et al. Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J. Gen. Virol. 2012, 93, 1624–1629, doi:10.1099/vir.0.042507-0.
[27]  Parchi, P.; Giese, A.; Capellari, S.; Brown, P.; Schulz-Schaeffer, W.; Windl, O.; Zerr, I.; Budka, H.; Kopp, N.; Piccardo, P.; et al. Classification of sporadic creutzfeldt-jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 1999, 46, 224–233, doi:10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W.
[28]  Nicot, S.; Bencsik, A.; Morignat, E.; Mestre-Frances, N.; Perret-Liaudet, A.; Baron, T. Differentiation of prions from l-type bse versus sporadic creutzfeldt-jakob disease. Emerg. Infect. Dis. 2012, 18, 2028–2031, doi:10.3201/eid1812.120342.
[29]  Castilla, J.; Gutierrez Adan, A.; Brun, A.; Pintado, B.; Ramirez, M.A.; Parra, B.; Doyle, D.; Rogers, M.; Salguero, F.J.; Sanchez, C.; et al. Early detection of prpres in bse-infected bovine prp transgenic mice. Arch. Virol. 2003, 148, 677–691, doi:10.1007/s00705-002-0958-4.
[30]  Hamir, A.N.; Miller, J.M.; O'Rourke, K.I.; Bartz, J.C.; Stack, M.J.; Chaplin, M.J. Transmission of transmissible mink encephalopathy to raccoons (procyon lotor) by intracerebral inoculation. J. Vet. Diagn. Invest. 2004, 16, 57–63, doi:10.1177/104063870401600110.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133